The San Francisco Chronicle reports that the California Assembly Health Committee voted against SB1096, which would have allowed pharmacies to sell customers’ prescription data for marketing purposes. The state Senate passed the bill in May.
Under SB1096, pharmaceutical companies would have been allowed to send mailings directly to patients suffering from such illnesses as cancer, Parkinson’s disease and schizophrenia. Drugmakers would have been able to contract with mailing firms that in turn would have paid fees to pharmacies.
Read my previous post on this bill and its significant privacy implications here.